Investor Presentaiton slide image

Investor Presentaiton

Consolidated Cash Flow Cash Flow Statement (Rs. Crs) Profit Before Tax FY22 FY21 293.4 244.3 Adjustments for Depreciation and other items 58.8 76.8 Operating profit before working capital changes 352.2 321.2 Changes in working capital -16.4 -15.3 Cash generated from operations 335.8 305.9 Direct taxes paid (net of refund) -82.5 -56.8 Net Cash from Operating Activities (A) 253.3 249.0 Net Cash from Investing Activities (B) -737.6 61.7 Net Cash from Financing Activities (C) 162.5 -32.7 Net Change in cash and cash equivalents -321.8 278.0 METROPOLIS The Pathology Specialist 20 20
View entire presentation